chrisvoncsefalvay/vaers-outcomes huggingface dataset:
was sweating profusely and breathing heavy then he passed out; was sweating profusely and breathing heavy then he passed out; was sweating profusely and breathing heavy then he passed out; he started getting dizzy; felt nauseated; This is a spontaneous report from a contactable consumer (patient's parent).    A 16-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 11Apr2021 14:30 (Lot Number: EW0150) (age at vaccination: 16-year-old) as SINGLE DOSE for covid-19 immunisation. Medical history was reported as no. No COVID prior vaccination, no COVID tested post vaccination, no Known allergies. There were no concomitant medications (no other vaccine in four weeks and no other medications in two weeks).  Right after the patient was administered the vaccine, he started getting dizzy and felt nauseated, was sweating profusely and breathing heavy then he passed out. They were in the car so the nurse reclined his chair. He passed out and then woke up and then passed out (twice) -They gave him water and gum to chew and remained laying flat. After about 20 or so minutes he felt better and nurse checked his pulse and heart rate during the ordeal. The adverse events start date was reported as 11Apr2021 14:30. No treatment received for the events. The outcome of the events was recovered.
Information has been received from a lawyer regarding a case in litigation which was reported, concerning a 43 year old female with pharyngitis streptococcal and had a generic background to develop autoimmunity who on 08-MAY-1998 was vaccinated with a third dose of RECOMBIVAX HB (manufacturer unknown). It was reported that one month later the patient received the vaccine, she complained of pain in the right knee and neck, a rash and a low-grade fever and saw the physician. Three theories were reported by the physician in this case to describe patient's autoimmune process to explain the reaction to the vaccine. The physician reported that the vaccine whose purpose was to enhance the immune reaction but, in this case, overstimulated it, and failed to develop antibodies to the vaccine but still reacted to the shot. The physician's preferred diagnosis for the patient was nonspecific arthritis, an undefined connective tissue disease, He also mentioned that patient had seronegative rheumatoid arthritis because of the absence of positive rheumatoid factor, or "epitope spreading" where the immune system developed autoantibodies or antibodies toward a part of molecule in the vaccine that was similar to the individual's own body, in this case the enzyme polymerase. The special master reported that all of those mentioned theories by the physician were plausible. Another physician reported that patient had elevated white blood count (WBC) but was not sure of the significance of the elevated WBC. The patient's outcome was unknown. No other information is available.
Multiple retinal artery occlusions in both eyes 3 days following his booster dose  with a negative workup.  I am a retinal specialist, and he underwent Echocardiogram, Carotid imaging / Neuro imagining, a herpercoaguable workup including an oncology referral / and cardiology referral.
LARGE RED AREA AT INJECTION SITE THAT HAD A KNOT UNDER THE SKIN AND WAS PAINFUL TO THE PATIENT, ALSO SHE STATED IT WAS WARM TO THE TOUCH
she had some little pain in the arm where she got it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "she had some little pain in the arm where she got it". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a consumer refers to herself, a 61 year old female patient with an allergy to amoxicillin. The patient's pertinent medical history included chickenpox and pneumonia. On an unknown date in June 2014, the patient was vaccinated in the back of the arm with one dose of ZOSTAVAX (lot number J014812 and expiration date 20-FEB-2015, exact dose and route of administration were not reported). Concomitant therapies included ZYRTEC. On an unknown date in June 2014 (reported as on the day of vaccination), the patient experienced itching 6 inch diameter welt, joint pain, fever, chills, rash and a red arm from elbow to shoulder. The patient was given BENADRYL and ibuprofen as treatment for the events. There were no lab diagnostics studies performed. The patient recovered from the events of chills and rash on an unknown date in 2014 (reported as the chills lasted for a couple of days and the rash did not go away for one week). The patient recovered from the other events on an unknown date. The patient sought medical attention, she called the physician's office. The relatedness between the events and the ZOSTAVAX was not reported. Additional information has been requested.
First I reported a lot of soreness and stiffness in my left arm.  Could not raise it above shoulder without discomfort until 4/1/2021.  Then, at that time I started getting chills.  Thinking I may have been exposed to Covid, I took the test which was negative.  Everyday I have a temp between 99.5 and 100.  I do not know if this is connected to the vaccine but I am tired.  I feel like I may have an infection but no other symptoms.
Information has been received from a physician assistant's nurse concerning a 73 year old male who on 17-MAR-2009 was vaccinated with the first 0.65 ml dose of ZOSTAVAX (Merck) (therapy route and lot # not provided). Concomitant therapy included a statin and Angiotensin Converting Enzyme (ACE) inhibitor. On 27-SEP-2010 the patient presented with shingles with severe pain even though he was given ZOSTAVAX (Merck). The patient was given VALTREX (GSK) for this AE. The patient sought unspecified medical attention. At the time of report, the patient's present status was not recovered. This is one of several reports from the same source. Additional information has been requested.
She has had persistent pain at site of injection. Significant enough that she's not been able to sleep normally due to pain. No signs of infection or inflammation.
Site of injection was very swollen for 2 weeks. It took 30 days for the swelling to completely go away.
Mother called on 2-9-2010 to report child had a reaction to vaccine given on 6-11-2009. Stated child later went to ER with temp of 105 or more. She did not report any lasting effects but she stated she had forgotten to call and report the event.
VACCINE  WAS ADMINISTERED WHEN EXPIRED BY 45 MINUTES - 1 HOUR (PAST THE  ALLOWED 6 HOURS AFTER FIRST PUNCTURE); This spontaneous report received from a pharmacist concerned a 39 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, expiry: 02-OCT-2021) dose was not reported, administered on 13-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-AUG-2021, the patient experienced vaccine was administered when expired by 45 minutes - 1 hour (past the allowed 6 hours after first puncture). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine was administered when expired by 45 minutes - 1 hour (past the allowed 6 hours after first puncture) was not reported. This report was non-serious.
15 minutes after the vaccine was given the patient began to feel warm and nauseated.   She had a near syncopal event.   She stated history of similar episode with blood draw.
Severe rash/hives on lower legs and upper chest that started about 6 hours after injection (resolved about 24 hrs after presentaion); general malaise (headache, lethargy, lower leg weakness  and hot/cold flashes) lasting for 24-48 hrs (all of these starting about 12 hours after injection).
Got Chicken pox; This spontaneous case was reported by a consumer and describes the occurrence of VARICELLA (Got Chicken pox) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VARICELLA (Got Chicken pox). At the time of the report, VARICELLA (Got Chicken pox) outcome was unknown.            No concomitant medications provided  No treatment medications provided
Patient was extremely nervous prior to getting vaccine.  After receiving vaccination, she felt light headed and nauseous.  She explained that she always feels this way after getting vaccines or getting blood drawn.  Patient was given water and sat down for 30 minutes.  After 30 minutes, patient felt much better and was able to leave the pharmacy without treatment.
cough; started with a temperature; This is a spontaneous report from a non-contactable consumer (reporting for her mother). This 67-year-old female received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and Expiration date unspecified) on unspecified date in Jan2021 (at 67 years of age) as single dose for COVID-19 immunisation.  Medical history was reported as none. Concomitant medications were not reported. On Jan2021, the patient experienced cough and started with a temperature.   Outcome of event 'cough' was unknown and 'started with a temperature' was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I am not sure if my medical provider had reported this reaction to VAERS at the time, but I had a severe serum sickness type of reaction to this vaccine 7 days after I got it, it started out with a whole body rash and then resulted in severe polyarthritis in all joints to the point where I was in severe pain and could not move any joint in my body. I had a very high WBC count of 17.4 noted as well as serum inflammatory markers, low albumin when I had gone to the ER. I needed to see rheumatology afterwards and had to take a month long high dose prednisone taper in order for symptoms to resolve.
A little soreness at the injection site; kind of tired; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 76-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient's medical history included ongoing dust and dust mites, trees and grass. The patient's concomitant medications were not reported. It was reported that the patient receives an allergy shot every 3 weeks and has done so since 2009. She receives the allergy shot in one arm for dust and dust mites, and another in the other arm for trees and grass. On an unspecified date, the patient also reports that after receiving her first dose, she experienced a little soreness at the injection site and reports feeling kind of tired but states she haven't really experienced anything else. She was okay. She hasn't had anything significant. The patient would like to know if there was any information regarding blood thinners and taking the vaccine. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Patient presented to office today (8-10-10) for GARDASIL #3 and reports she had difficulty breathing and tachycardia after receiving MCV-4 and HEP A #1 on 7-16-10.  States symptoms started about 30 min after shots. Went to doctor. No tx given.
Vaccine given high up on shoulder, not 3 finger widths down. Persistent pain right shoulder and upper arm, positional discomfort. Pocket of fluid accumulation above right clavicle.
VARIVAX was administered after undergoing a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 19-JUL-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (dosage regimen was not reported), lot # T028310 and expiration date 20-AUG-2022 administered as prophylaxis.  The improperly stored dose of the suspect vaccine experienced a temperature excursion of 0.4 degree celsius (°C) for 13 hours and 10 minutes on an unspecified date); no previous temperature excursions were reported.   The call was made due to a digital data logger.   This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-2107USA006887: US-009507513-2107USA006957: US-009507513-2107USA007000: US-009507513-2107USA007007: US-009507513-2107USA007007:
Pain and swelling on left deltoid where Tdap was injected; generalized itching.
Initial report was received via a search of the scientific literature on 03 June 2011. The patient captured in this case was one of eight patients noted in the article who experienced anaphylaxis after receiving a diphtheria, tetanus and acellular pertussis containing vaccine (manufacturer unknown). These patients tolerated their initial vaccinations but reacted to booster doses. A 5-year-old male patient had received an injection of DTaP vaccine (manufacturer unknown, lot number, route, site and date of administration not reported) and immediately after vaccination, he developed anaphylaxis with symptoms of generalized urticaria, facial swelling, wheezing, retractions and difficulty breathing. Corrective treatments consisted of diphenhydramine and epinephrine. The patient had a history of asthma and milk allergy demonstrated by urticaria, edema of the face, and wheezing after contact with milk-based formula at two years of age. Laboratory testing showed the patient had increased IgE levels (>100) within two years of vaccination. Outcome was not reported. This patient had previously been referenced in case number 2011-01614. The other seven patients have been captured in case numbers 2011-03272, -03275, -03277, -03278, -03279, -03280 and -03281. Documents held by sender: None.
Information has been received from an office manager referring to an unknown number of unspecified patients (age and gender unknown). The patients' concurrent conditions, concomitant medication and medical history were not provided. On unknown dates starting on or after 28-APR-2016, the patients were vaccinated with improperly stored doses of VAQTA (lot # was reported as M017982, expiry date 13-SEP-2017, strength, dose, route and dose number were not provided). The vaccine was exposed to a temperature of 28.6 F for a time frame of 885 hours. There was no previous temperature excursion. "Data logger" was involved. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Redness to site. On 08/27/2010, area on right upper thigh increased in redness and swelling to a size of 14.5 cm x17 cm. TX. Ice to area with Childrens Benadryl. Improvement on 08/30/2010.
Patient stated that After receiving the second vaccine the left side of her face went numb. She also felt that her body was heated from the inside out. She didn't think much of it. That lasted about three days. After receiving the booster she felt  like her body was burning on the inside and that her nerves was being hit with a ciggeratte. Her bones and muscles were aching. She could not turn her neck very good. Her legs and face were tingling. The legs are still tingling. Her face is bright red and her arm has a big red rash. She a headache. Extreme fatigue and her eyes felt like sandpaper.
I had a sinus infection and it was months after the vaccine, I was just congested and sore throat with a cough.
Weak; tired; difficulty breathing; Loss of taste or smell. I took over the counter medication. Developed pneumonia; I also contracted Covid-19.
Date and time adverse event started: 3/26/21 0345 Patient had syncopal episode on toilet; has hx of vasovagal syncope per husband; patient also developed headache on 3/28/21 7pm. Took tylenol with good relief  What happened as a result of the adverse event? (doctor visit, ED or urgent care visit, hospitalization, life threatening illness, disability/permanent damage, death, none of these):  Spoke with Cardiologist re: syncopal episode and elevated HR at rest
This spontaneous report as received from a nurse refers to a 5 years 5 months old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) LIQUID PEDVAXHIB injection, lot # K016965, exp. date: 20-JUL-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Patient came in 2 weeks after vaccination in upper  left arm complaining itchy red rash on upper arm from shoulder down to upper forearm
Information has been received from a registered nurse concerning an 8 year old male who in the morning of 21-DEC-2001 was vaccinated with a first subcutaneous dose in the left arm of varicella virus vaccine live (Oka/Merck) (Lot # 638245/0779L). On 20-OCT-2007, the patient developed rash all over body with 50 to 500 lesions. At the time of report the patient had recovered. A product quality complaint was not involved. Additional information has been requested. This is one of several reports received from the same source.
pt devel high fever @ least 103.4 ax; pt was unconsolable for 1 hr until temp came down; devel cold sx on 26MAY94;
Per guidance, after the vaccine was administered I waited 15 minutes in the monitored waiting area. I felt fine and was released. I got in my vehicle and began driving home. Within 5-10 minutes of driving my left ear (same side as the vaccination), began to fill like it was clogged or needed to pop like being at a higher altitude. It has felt this way ever since. As of today, it has been 11 days of my ear feeling clogged or needing to pop. I reached out to my functional doctor, and have since been trying to identify a doctor to go see for this issue.
patient reported: Received influenza vaccine on afternoon of  Friday 10/7/22 and within 12-24 hours felt "extremely irritable." Came for shift at work on Saturday 10/8/22 and continued to feel "irritable, so much so that it caused her to lash out at a coworker and had to be sent home."  Also reported "brain fog."  Irritability and brain fog lasted approximately 48 hours per patient.
Local soreness, redness and swelling at injection site lasting 3 days. Fever for 3 days with highest 101.5, gradually decreasing by end of third day, accompanied by intermittent chills. Muscle aches in arms, shoulders and back for 3 days. Extreme fatigue that gradually decreased over about  5 days. Slight nausea and lack of appetite for about 3 days. Headache for 2 days.
Got vaccine at 1100am  Starting at about 1100pm, I developed shaking chills, myalgia, Frontal Headache, nausea. I had redness and soreness at site of injection. Symptoms resolved within 24hrs with help from Tylenol.
Information has been received from a certified medical assistant concerning a 6 month old female with no past medical history and no allergies who on 28-NOV-2006 was vaccinated with PedvaxHIB (lot#653300/0277F) (0.5 ml), IM. Concomitant therapy that day included Prevnar and Pediarix. There was no other concomitant medication. On 30-NOV-2006 the patient experienced red raised papular rash at the injection site. There were no relevant diagnostic tests of laboratory data. At the time of the report, the patient was recovering. Additional information has been requested.
Case vaccinated with moderna x 2 in 2021. Tested positive for Covid 19 on 08/02/2022. Admitted to  Medical Center on 8/14/2022 and expired on 08/15/2022 while still hospitalized.
Bruise to Antecubital of opposite arm, denied having it prior to the vaccine being administered. No Resp. Diff, No urticaria, no Signs or symptoms of an allergic reaction. No localized pain to bruise site.
Admitted to hospitals with fevers, fatigue, and general malaise. Requiring supplemental O2
I am breastfeeding. My milk supply decreased dramatically. My period also started. I haven't had a period since September 2019. I believe they are related.
I got really sick from  one; Initial information was received on 02-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media .  This case involves a patient (unknown demographics) who got really sick from one (Illness), while received INFLUENZA VACCINE..  Medical history, past medical treatment, vaccination, family history and concomitant medications were not provided.   On an unknown date, the patient received an INFLUENZA VACCINE (Produced by unknown manufacturer) (lot number, expiry date and other dosing details were not reported) for unknown indication.  On an unknown date, was got really sick from one (Illness), (unknown latency), following the administration of INFLUENZA VACCINE.   Details of laboratory data not reported.  Corrective treatment and outcome were unknown at the time of reporting.  There will be no information available on the batch number for this case.
This case was reported by a healthcare professional and described the occurrence of injection site rash in a 40 year old male subject who was vaccinated with FluLaval for prophylaxis. On 17 November 2006 the subject received a dose of FluLaval in an unspecified arm. On 17 November 2006, the subject also received Havrix at an unspecified site of injection. The next day, on 18 November 2006, the healthcare professional noted that at the site of the FluLaval injection the subject experienced "a breakout of rash on the arm of the injection site with a black dot in the middle of the injection site. " The events were completely resolved by 20 November 2006. In the reporter's opinion, the events were possibly related to treatment with FluLaval.
Morning after vaccine administration, patient felt severely weak, flu like symptoms, shivering and sick to stomach.